Evidence map›Paper›PMID 31605353›Full record

ArticleLa Radiologia medica2020

Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings.

Davide Franceschini, Alessio Bruni, Paolo Borghetti, Niccolò Giaj-Levra, Sara Ramella, Lucio Buffoni, Serena Badellino, Maria Andolina, Camilla Comin, Emanuela Vattemi and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in La Radiologia medica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Lung Cancer Imaging: Screening Result and Nodule Management.International journal of environmental research and public health · 2022
    Pooled it
  2. Article
  3. Review
  4. Smile InHealthcare (Basel, Switzerland) · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Davide FranceschiniRadiation Oncology Department, Humanitas Research Hospital and Cancer Center, Via Manzoni 56, 20089, Rozzano, Milan, Italy. davide.franceschini@humanitas.it.ORCID http://orcid.org/0000-0003-1142-2439
Alessio BruniRadiotherapy Unit, University Hospital of Modena, Modena, Italy.
Paolo BorghettiRadiation Oncology Department, ASST Spedali Civili and University of Brescia, Brescia, Italy.
Niccolò Giaj-LevraAdvanced Radiation Oncology Department, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy.
Sara RamellaRadiation Oncology Department, Campus Bio-Medico, Rome, Italy.
Lucio BuffoniOncology Department, San Luigi Hospital University of Turin, Orbassano, Turin, Italy.
Serena BadellinoRadiation Oncology Department, A.O.U. Città della Salute e della Scienza, Turin, Italy.
Maria AndolinaRadiotherapy Unit, University Hospital of Modena, Modena, Italy.
Camilla CominDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Emanuela VattemiOncology Unit, Central Hospital, Bolzano, Italy.
Michela BezziEndoscopic Pneumology Unit, ASST Spedali Civili Brescia, Brescia, Italy.
Marco TrovòRadiation Oncology Department, Azienda Sanitaria Universitaria Integrata Udine, 33100, Udine, Italy.
Antonio PassaroDivision of Thoracic Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Alessandra BearzMedical Oncology Unit, Centro di Riferimento Oncologico-IRCCS, Aviano, Italy.
Rita ChiariMedical Oncology Unit, Ospedale Madre Teresa di Calcutta, "AULSS6 Euganea-Padova", Padua, Italy.
Franchina TindaraDepartment of Human Pathology of the Adult and Evolutive Age "G. Barresi", Messina, Italy.
Katia FerrariSection of Respiratory Medicine, Careggi University Hospital, Florence, Italy.
Gaia PipernoDivision of Radiotherapy, European Institute of Oncology, IRCCS, Milan, Italy.
Andrea Riccardo FilippiDepartment of Medical Sciences and Infectious Diseases, Unit of Radiation Therapy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Domenico GenovesiRadiation Oncology Department, SS. Annunziata Hospital, "G. D'Annunzio" University of Chieti, Chieti, Italy.
Vieri ScottiDepartment of Oncology, Radiation Therapy Unit, Careggi University Hospital, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo report criticisms and barriers to the "real-life" application of international guidelines and recent developments in the management of locally advanced non-small cell lung cancer (NSCLC) in Italy.

methodsThree 2-day courses were organized. During the first day, experts in different fields of thoracic oncology gave their lecture on diagnosis and therapy for locally advanced NSCLC. During the second day, all participants were divided into four groups to discuss on a clinical case as a multidisciplinary team (MDT). The aim was to stimulate the discussion on practical issues in the management of NSCLC patients in the real-life practice.

resultsA total of 196 physicians were involved in the courses as learners. Invasive diagnosis of nodal disease for staging purposes, a priori definition of "surgical resectability" and a regular MDT with all crucial participants available were the three main key points identified for a good management of these patients. The main barriers to the clinical application of a good diagnostic and therapeutic approach to the patient were the absence of a regular and complete MDT in the South and Centre of Italy, while in the North of Italy, time for discussion of clinical cases in the MDT and waiting lists for staging and therapeutic interventions were deemed as the major concerns.

conclusionThe meetings showed that diagnosis and treatment of locally advanced NSCLC are still extremely variable between different Italian regions. Logistic issues, waiting lists, paucity of well-trained staff and expertise seem to be the main barriers to international guidelines application.

Indexed as

Patient Care TeamCarcinoma, Non-Small-Cell LungCongresses as TopicHumansInterdisciplinary CommunicationItalyLung NeoplasmsPractice Guidelines as TopicPractice Patterns, Physicians'Multidisciplinary evaluationNon small cell lung cancerStage III

Identifiers

PMID31605353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.